Improving Care

Reducing morbidity and mortality and enhancing quality of life

Informing Policy

Transforming health care at the local, national and international levels

Featured Projects

With more than 80 scientists, research at Advancing Health encompasses a wide breadth of areas


The Evidence Speaks

A recurring feature highlighting the latest in Advancing Health research

Our People

In the News

Research Resources

From design to execution, Advancing Health provides a broad range of support services

Work in Progress Seminar Series

Shirin Kalyan

Scientist, PHD

Dr. Shirin Kalyan is an Assistant Professor in the Division of Endocrinology, Department of Medicine at the University of British Columbia and the Director of Scientific Innovation at Qu Biologics, a clinical-stage Vancouver-based biotech company focused on restoring innate immune function in the context of chronic inflammatory disorders and cancer.

Research Interests

  • Innate immune function and Host-Microbiome interactions
  • Immunotherapy
  • Osteoimmunology and treatment of bone degenerative diseases
  • Inflammation and aging
  • Sex differences in disease pathophysiology

She earned her Ph.D. from the University of British Columbia in Experimental Medicine investigating the pivotal innate immune mediators of inflammation in the context of toxic shock syndrome.

Dr. Kalyan was subsequently awarded a 3-year fellowship from the Alexander von Humboldt Foundation to conduct research at the Institute of Immunology in Kiel, Germany. Her research interests include determining how to restore immune function in the context of cancer and chronic inflammatory diseases and understanding how drug therapies commonly used to treat chronic degenerative disorders affect immunity.